The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.

Retail investor sentiment around Hims & Hers Health remained negative over the weekend after the telehealth firm confirmed it ...

The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...

Skyline view of the City of London financial district from the viewpoint in Greenwich Park in London, United Kingdom. This is ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...